Perrigo | PRGO - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
AbbVie USD 645M 69M 2026-03
Abbott USD 68M 26M 2026-03
Bayer EUR 675M 87M 2025-12
Bristol-Myers Squibb USD 411M 21M 2026-03
Coherus Biosciences USD 2.25M 76K 2025-12
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Dr.Reddys Laboratories INR 1.06B 113M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
J&J USD 43M 25M 2026-03
Merck USD 479M 67M 2026-03
Nestle CHF 897M 32M 2025-12
Pacira USD 3.7M 193K 2026-03
Perrigo USD 7.98B 7.94B 2026-03
Pfizer USD 671M 40M 2026-03
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Reckitt Benckiser GBP 208M 198.3M 2024-12
Sanofi EUR 178M 203M 2026-03
Supernus Pharmaceuticals USD 910K 278K 2023-06
Teva Pharmaceutical Industries USD 216M 4M 2026-03
Xeris Pharmaceuticals USD 7.15M 115K 2025-12
Zoetis USD 62M 5M 2026-03